05/20/2026 | Press release | Distributed by Public on 05/20/2026 15:01
|
State of Israel
|
Not Applicable
|
|
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer
Identification No.)
|
|
|
2 Cabot Rd.
Hudson, MA
|
01749
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
|
Rachael M. Bushey, Esq.
Jennifer L. Porter, Esq.
Goodwin Procter LLP
3025 John F Kennedy Blvd
Philadelphia, PA 19104
Tel: (445) 207-7805
|
Aaron M. Lampert, Adv.
Ephraim Peter Friedman, Adv.
Goldfarb Gross Seligman & Co.
Azrieli Center, Round Tower
Tel Aviv 6701101, Israel
Tel: +972-3-607-4444
|
|
Large accelerated filer
|
☐
|
Accelerated filer
|
☐
|
|
Non-accelerated filer
|
☒
|
Smaller reporting company
|
☒
|
|
Emerging growth company
|
☐
|
|
|
• |
Options to purchase 33,333 ordinary shares granted to induce the recipient to accept employment as the Registrant's President and Chief Executive Officer, granted on June 2, 2025.
|
|
Item 3. Incorporation of Documents by Reference.
|
|
(i)
|
The Registrant's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the Commission on March 18, 2026;
|
|
|
(ii)
|
The Registrant's Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, filed with the Commission on May 20, 2026;
|
|
(iii)
|
The Registrant's Current Reports on Form 8-K (other than portions thereof furnished under Item 7.01 of Form 8-K and exhibits accompanying such reports that are related to such items) filed with the Commission on January 6, 2026, January 13, 2026, January 28, 2026, February 9, 2026, February 19, 2026, February 25, 2026, February 27, 2026, March 2, 2026, March 11, 2026, March 12, 2026, March 20, 2026, March 25, 2026, March 31, 2026, April 23, 2026, and May 19, 2026; and
|
|
(iv)
|
The description of the Registrant's Ordinary Shares contained in Item 1 of the Registration Statement on Form 8-A (File No. 001-36612) filed with the Commission on September 2, 2014, as updated by any amendment or report filed for the purpose of updating that description.
|
|
Item 6. Indemnification of Directors and Officers.
|
|
|
• |
financial liability imposed on him or her in favor of another person pursuant to a judgment, including a settlement or arbitrator's award approved by a court. However, if an undertaking to indemnify an office holder with respect to such liability is provided in advance, then such an undertaking must be limited to events which, in the opinion of the board of directors, can be foreseen based on the company's activities when the undertaking to indemnify is given, and to an amount or according to criteria determined by the board of directors as reasonable under the circumstances, and such undertaking shall detail the abovementioned foreseen events and amount or criteria;
|
|
|
• |
reasonable litigation expenses, including attorneys' fees, incurred by the office holder (1) as a result of an investigation or proceeding instituted against him or her by an authority authorized to conduct such investigation or proceeding, provided that (i) no indictment was filed against such office holder as a result of such investigation or proceeding; and (ii) no financial liability was imposed upon him or her as a substitute for the criminal proceeding as a result of such investigation or proceeding or, if such financial liability was imposed, it was imposed with respect to an offense that does not require proof of criminal intent; and (2) in connection with a monetary sanction; and
|
|
|
• |
reasonable litigation expenses, including attorneys' fees, incurred by the office holder or imposed by a court in proceedings instituted against him or her by the company, on its behalf, or by a third party, or in connection with criminal proceedings in which the office holder was acquitted, or as a result of a conviction for an offense that does not require proof of criminal intent.
|
|
|
• |
a breach of the duty of loyalty to the company, provided that the office holder acted in good faith and had a reasonable basis to believe that the act would not harm the company;
|
|
|
• |
a breach of duty of care to the company or to a third party, to the extent such a breach arises out of the negligent conduct of the office holder; and
|
|
|
• |
a financial liability imposed on the office holder in favor of a third party.
|
|
|
• |
a breach of the duty of loyalty, except for indemnification and insurance for a breach of the duty of loyalty to the company to the extent that the office holder acted in good faith and had a reasonable basis to believe that the act would not prejudice the company;
|
|
|
• |
a breach of duty of care committed intentionally or recklessly, excluding a breach arising out of the negligent conduct of the office holder;
|
|
|
• |
an act or omission committed with intent to derive illegal personal benefit; or
|
|
|
• |
a civil or criminal fine or forfeit levied against the office holder.
|
|
Item 8. Exhibits.
|
|
|
Exhibit
No. |
Description
|
|
|
|
||
|
|
||
|
5.1*
|
|
Opinion of Goldfarb Gross Seligman & Co., Israeli counsel to the Registrant, as to the validity of the ordinary shares (including consent).
|
|
23.1*
|
|
Consent of Kost, Forer, Gabbay and Kasierer, a member of Ernst & Young Global Limited.
|
|
23.2*
|
|
Consent of Goldfarb Gross Seligman & Co. (included in Exhibit 5.1).
|
|
24.1*
|
|
Power of Attorney (included on signature page).
|
|
|
||
|
99.2*#
|
|
Amendment No. 1 to the Lifeward Ltd. 2025 Incentive Compensation Plan.
|
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
107*
|
|
Filing Fee Table.
|
|
*
|
Filed herewith.
|
|
#
|
Denotes management contract or compensatory plan or arrangement.
|
|
Item 9. Undertakings.
|
|
|
LIFEWARD LTD.
|
||
|
By:
|
/s/ Almog Adar
|
|
|
Name:
|
Almog Adar
|
|
|
Title:
|
Chief Financial Officer
|
|
|
Signatures
|
Title
|
|
|
/s/ William Mark Grant
|
||
|
William Mark Grant
|
Director and President and Chief Executive Officer
(Principal Executive Officer)
|
|
|
/s/ Almog Adar
|
||
|
Almog Adar
|
Chief Financial Officer
(Principal Financial Officer and Principal Accounting Officer)
|
|
|
/s/ Robert J. Marshall
|
||
|
Robert J. Marshall
|
Chairman, Director
|
|
|
/s/ Michael Swinford
|
||
|
Michael Swinford
|
Director
|
|
|
/s/ William Mark Sigsbee
|
||
|
William Mark Sigsbee
|
Director
|
|
|
/s/ Nadav Kidron
|
||
|
Nadav Kidron
|
Director
|
|
|
/s/ Miriam Kidron, Ph.D
|
||
|
Miriam Kidron, Ph.D.
|
Director
|
|
|
/s/ Yehuda Reznick
|
||
|
Yehuda Reznick
|
Director
|
|
|
/s/ Moshe H. Rozenbaum
|
||
|
Moshe H. Rozenbaum
|
Director
|
|